162 related articles for article (PubMed ID: 9690454)
1. Colon cancer cell vaccine prepared with replication-deficient vaccinia viruses encoding B7.1 and interleukin-2 induce antitumor response in syngeneic mice.
Sivanandham M; Shaw P; Bernik SF; Paoletti E; Wallack MK
Cancer Immunol Immunother; 1998 Jul; 46(5):261-7. PubMed ID: 9690454
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of a vaccinia colon oncolysate prepared with interleukin-2 gene-encoded vaccinia virus and interferon-alpha increases the survival of mice bearing syngeneic colon adenocarcinoma.
Tanaka N; Sivanandham M; Wallack MK
J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):283-93. PubMed ID: 7881637
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model.
Sivanandham M; Scoggin SD; Tanaka N; Wallack MK
Cancer Immunol Immunother; 1994 Apr; 38(4):259-64. PubMed ID: 8168121
[TBL] [Abstract][Full Text] [Related]
4. Construction and characterization of a triple-recombinant vaccinia virus encoding B7-1, interleukin 12, and a model tumor antigen.
Carroll MW; Overwijk WW; Surman DR; Tsung K; Moss B; Restifo NP
J Natl Cancer Inst; 1998 Dec; 90(24):1881-7. PubMed ID: 9862625
[TBL] [Abstract][Full Text] [Related]
5. Vaccine therapy of established tumors in the absence of autoimmunity.
Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
[TBL] [Abstract][Full Text] [Related]
6. IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.
Rao JB; Chamberlain RS; Bronte V; Carroll MW; Irvine KR; Moss B; Rosenberg SA; Restifo NP
J Immunol; 1996 May; 156(9):3357-65. PubMed ID: 8617961
[TBL] [Abstract][Full Text] [Related]
7. Active specific immunotherapy of murine colon adenocarcinoma with recombinant vaccinia/interleukin-2-infected tumor cell vaccines.
Bash JA
Ann N Y Acad Sci; 1993 Aug; 690():331-3. PubMed ID: 8368746
[No Abstract] [Full Text] [Related]
8. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity.
Aarts WM; Schlom J; Hodge JW
Cancer Res; 2002 Oct; 62(20):5770-7. PubMed ID: 12384537
[TBL] [Abstract][Full Text] [Related]
9. A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model.
Jack AM; Aydin N; Montenegro G; Alam K; Wallack M
J Surg Res; 2007 May; 139(2):164-9. PubMed ID: 17275030
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7.
Akagi J; Hodge JW; McLaughlin JP; Gritz L; Mazzara G; Kufe D; Schlom J; Kantor JA
J Immunother; 1997 Jan; 20(1):38-47. PubMed ID: 9101412
[TBL] [Abstract][Full Text] [Related]
11. Immunization with a syngeneic tumor infected with recombinant vaccinia virus expressing granulocyte-macrophage colony-stimulating factor (GM-CSF) induces tumor regression and long-lasting systemic immunity.
McLaughlin JP; Abrams S; Kantor J; Dobrzanski MJ; Greenbaum J; Schlom J; Greiner JW
J Immunother; 1997 Nov; 20(6):449-59. PubMed ID: 9409450
[TBL] [Abstract][Full Text] [Related]
12. Recombinant vaccinia interleukin-2-infected tumor cell vaccines in immunotherapy of murine colon adenocarcinoma.
Bash JA
J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):269-72. PubMed ID: 8280707
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine.
Kantor J; Irvine K; Abrams S; Kaufman H; DiPietro J; Schlom J
J Natl Cancer Inst; 1992 Jul; 84(14):1084-91. PubMed ID: 1619682
[TBL] [Abstract][Full Text] [Related]
14. Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule.
Hörig H; Lee DS; Conkright W; Divito J; Hasson H; LaMare M; Rivera A; Park D; Tine J; Guito K; Tsang KW; Schlom J; Kaufman HL
Cancer Immunol Immunother; 2000 Nov; 49(9):504-14. PubMed ID: 11092617
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of colon tumor cells expressing FLT-3 ligand plus systemic IL-2 in mice with syngeneic colon cancer.
Sivanandham M; Stavropoulos CI; Kim EM; Mancke B; Wallack MK
Cancer Immunol Immunother; 2002 Apr; 51(2):63-71. PubMed ID: 11904730
[TBL] [Abstract][Full Text] [Related]
16. Prevention of hepatocellular carcinoma in mice by IL-2 and B7-1 genes co-transfected liver cancer cell vaccines.
Ge NL; Ye SL; Zheng N; Sun RX; Liu YK; Tang ZY
World J Gastroenterol; 2003 Oct; 9(10):2182-5. PubMed ID: 14562374
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies of a retrovirus versus a poxvirus vector in whole tumor-cell vaccines.
Hodge JW; Schlom J
Cancer Res; 1999 Oct; 59(20):5106-11. PubMed ID: 10537283
[TBL] [Abstract][Full Text] [Related]
18. A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice.
Xiang R; Primus FJ; Ruehlmann JM; Niethammer AG; Silletti S; Lode HN; Dolman CS; Gillies SD; Reisfeld RA
J Immunol; 2001 Oct; 167(8):4560-5. PubMed ID: 11591784
[TBL] [Abstract][Full Text] [Related]
19. Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines.
Dunussi-Joannopoulos K; Dranoff G; Weinstein HJ; Ferrara JL; Bierer BE; Croop JM
Blood; 1998 Jan; 91(1):222-30. PubMed ID: 9414288
[TBL] [Abstract][Full Text] [Related]
20. NYVAC vector modified by C7L viral gene insertion improves T cell immune responses and effectiveness against leishmaniasis.
Sánchez-Sampedro L; Mejías-Pérez E; S Sorzano CÓ; Nájera JL; Esteban M
Virus Res; 2016 Jul; 220():1-11. PubMed ID: 27036935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
